No there is no registered clinical trial of the GLOW combination
Because the compound lacks regulatory approval, any product marketed for human use is being sold through unofficial channels that do not meet pharmaceutical manufacturing standards, raising documented concerns about purity, composition, and contamination
Description History CJC-1295 (with DAC) is a synthetic analog of endogenous human growth hormone-releasing hormone GHRH(129)NH, modified at four amino acid positions to reduce susceptibility to dipeptidylpeptidase-4 (DPP-4) and other proteolytic enzymes, and bearing a maleimidopropionic acid (MPA) moiety the Drug Affinity Complex (DAC) at a specific Lys residue that enables covalent conjugation to circulating albumin via Michael addition
This interaction is mechanistically consistent with the observation that the protective effect of high broccoli intake against colorectal adenomas was exclusively evident in individuals with the GSTM1-null genotype, likely due to prolonged tissue exposure to bioactive ITCs (60)
data from Fe-treated gsh mutant cells were compared to untreated gsh cells, and data from the gsh strain were compared to WT cells